Article ISI
JOURNAL OF CLINICAL ONCOLOGY  (2021)

Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post hoc analysis of the randomized, phase 3 KEYNOTE-240 study.

GARRIDO, Marcelo

Más información

Título según WOS: Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post hoc analysis of the randomized, phase 3 KEYNOTE-240 study.
Título de la Revista: JOURNAL OF CLINICAL ONCOLOGY
Volumen: 39
Número: 15
Editorial: LIPPINCOTT WILLIAMS & WILKINS
Fecha de publicación: 2021
DOI:

10.1200/JCO.2021.39.15_suppl.e16122
Notas: ISI